The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cannabinoid-based Antitumor Drug-Global Market Insights and Sales Trends 2024
Synopsis
The global Cannabinoid-based Antitumor Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cannabinoid-based Antitumor Drug in various end use industries. The expanding demands from the Clinics, Hospitals and Others,, are propelling Cannabinoid-based Antitumor Drug market. Chewing Medicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lozenge segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cannabinoid-based Antitumor Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cannabinoid-based Antitumor Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cannabinoid-based Antitumor Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cannabinoid-based Antitumor Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cannabinoid-based Antitumor Drug covered in this report include Cannabics Inc., Tikun Olam, Jay Pharma, GW Pharmaceuticals, Medicanja Ltd and Valeant Pharmaceuticals, etc.
The global Cannabinoid-based Antitumor Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cannabics Inc.
Tikun Olam
Jay Pharma
GW Pharmaceuticals
Medicanja Ltd
Valeant Pharmaceuticals
Global Cannabinoid-based Antitumor Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cannabinoid-based Antitumor Drug market, Segment by Type:
Chewing Medicine
Lozenge
Other
Global Cannabinoid-based Antitumor Drug market, by Application
Clinics
Hospitals
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cannabinoid-based Antitumor Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cannabinoid-based Antitumor Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cannabinoid-based Antitumor Drug in various end use industries. The expanding demands from the Clinics, Hospitals and Others,, are propelling Cannabinoid-based Antitumor Drug market. Chewing Medicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lozenge segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cannabinoid-based Antitumor Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cannabinoid-based Antitumor Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cannabinoid-based Antitumor Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cannabinoid-based Antitumor Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cannabinoid-based Antitumor Drug covered in this report include Cannabics Inc., Tikun Olam, Jay Pharma, GW Pharmaceuticals, Medicanja Ltd and Valeant Pharmaceuticals, etc.
The global Cannabinoid-based Antitumor Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cannabics Inc.
Tikun Olam
Jay Pharma
GW Pharmaceuticals
Medicanja Ltd
Valeant Pharmaceuticals
Global Cannabinoid-based Antitumor Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cannabinoid-based Antitumor Drug market, Segment by Type:
Chewing Medicine
Lozenge
Other
Global Cannabinoid-based Antitumor Drug market, by Application
Clinics
Hospitals
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cannabinoid-based Antitumor Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cannabinoid-based Antitumor Drug
1.1 Cannabinoid-based Antitumor Drug Market Overview
1.1.1 Cannabinoid-based Antitumor Drug Product Scope
1.1.2 Cannabinoid-based Antitumor Drug Market Status and Outlook
1.2 Global Cannabinoid-based Antitumor Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cannabinoid-based Antitumor Drug Market Size by Region (2018-2029)
1.4 Global Cannabinoid-based Antitumor Drug Historic Market Size by Region (2018-2023)
1.5 Global Cannabinoid-based Antitumor Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cannabinoid-based Antitumor Drug Market Size (2018-2029)
1.6.1 North America Cannabinoid-based Antitumor Drug Market Size (2018-2029)
1.6.2 Europe Cannabinoid-based Antitumor Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size (2018-2029)
1.6.4 Latin America Cannabinoid-based Antitumor Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size (2018-2029)
2 Cannabinoid-based Antitumor Drug Market by Type
2.1 Introduction
2.1.1 Chewing Medicine
2.1.2 Lozenge
2.1.3 Other
2.2 Global Cannabinoid-based Antitumor Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2018-2029)
3 Cannabinoid-based Antitumor Drug Market Overview by Application
3.1 Introduction
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Others
3.2 Global Cannabinoid-based Antitumor Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2018-2029)
4 Cannabinoid-based Antitumor Drug Competition Analysis by Players
4.1 Global Cannabinoid-based Antitumor Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cannabinoid-based Antitumor Drug as of 2022)
4.3 Date of Key Players Enter into Cannabinoid-based Antitumor Drug Market
4.4 Global Top Players Cannabinoid-based Antitumor Drug Headquarters and Area Served
4.5 Key Players Cannabinoid-based Antitumor Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Cannabinoid-based Antitumor Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cannabics Inc.
5.1.1 Cannabics Inc. Profile
5.1.2 Cannabics Inc. Main Business
5.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.1.4 Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Cannabics Inc. Recent Developments
5.2 Tikun Olam
5.2.1 Tikun Olam Profile
5.2.2 Tikun Olam Main Business
5.2.3 Tikun Olam Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.2.4 Tikun Olam Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Tikun Olam Recent Developments
5.3 Jay Pharma
5.3.1 Jay Pharma Profile
5.3.2 Jay Pharma Main Business
5.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.3.4 Jay Pharma Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2018-2023)
5.3.5 GW Pharmaceuticals Recent Developments
5.4 GW Pharmaceuticals
5.4.1 GW Pharmaceuticals Profile
5.4.2 GW Pharmaceuticals Main Business
5.4.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.4.4 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2018-2023)
5.4.5 GW Pharmaceuticals Recent Developments
5.5 Medicanja Ltd
5.5.1 Medicanja Ltd Profile
5.5.2 Medicanja Ltd Main Business
5.5.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.5.4 Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Medicanja Ltd Recent Developments
5.6 Valeant Pharmaceuticals
5.6.1 Valeant Pharmaceuticals Profile
5.6.2 Valeant Pharmaceuticals Main Business
5.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.6.4 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Valeant Pharmaceuticals Recent Developments
6 North America
6.1 North America Cannabinoid-based Antitumor Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cannabinoid-based Antitumor Drug Market Dynamics
11.1 Cannabinoid-based Antitumor Drug Industry Trends
11.2 Cannabinoid-based Antitumor Drug Market Drivers
11.3 Cannabinoid-based Antitumor Drug Market Challenges
11.4 Cannabinoid-based Antitumor Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
